Multidisciplinary system for detecting medication errors in antineoplastic chemotherapy

Journal of Oncology Pharmacy Practice

Volumn 16, Issue 2, 2010, Pages 105-112

  Serrano Fabiá, Amparo ^a   Albert Marí, Asunción ^a,b   Almenar Cubells, Daniel ^b   Victor Jimenez Torres N ^a  

^a HOSPITAL DE MANACOR   (Spain)

^b HOSPITAL UNIVERSITARIO DR PESET   (Spain)

Author keywords

Antineoplastic treatment; Computerized pharmacotherapy process; Cross validation; Medication errors; Multidisciplinary system; Severity

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; COMPUTER AIDED DESIGN; COMPUTER SYSTEM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEALTH PERSONNEL ATTITUDE; HUMAN; INTEGRATED HEALTH CARE SYSTEM; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICATION ERROR; ONCOLOGY WARD; PATIENT CARE; PRIORITY JOURNAL; TOTAL QUALITY MANAGEMENT; VALIDATION PROCESS;

ANTINEOPLASTIC AGENTS; COHORT STUDIES; FOLLOW-UP STUDIES; HOSPITALS, UNIVERSITY; HUMANS; INTERPROFESSIONAL RELATIONS; LONGITUDINAL STUDIES; MEDICATION ERRORS; MEDICATION SYSTEMS, HOSPITAL; NURSES; PHARMACISTS; PHYSICIANS; PROSPECTIVE STUDIES;

EID: 77952765467     PISSN: 10781552     EISSN: None     Source Type: Journal    
DOI: 10.1177/1078155209340482     Document Type: Article

References (38)

1. Galanter WL, Polikaitis A., DiDomenico R. A trial of automated safety alerts for unpatient digoxine use with computerized physician order entry. J Am Inform Assosc 2004 ; 11: 270-277.
2. Ernst FR, Grizzle A.J. Drug-related morbidity and mortality: updating the cost-of-illness model. J Am Pharm Assoc (Wash) 2001 ; 41 (2). 192-199.
3. Kelly WN Potential risk and prevention, Part I: Fatal adverse drug events. Am J Health Syst Pharm 2001 jul 15; 58 (14). 1317-1324.
4. Kelly WN Potential risk and prevention, Part II: Drug-induced permanent disabilities. Am J Health Syst Pharm 2001 jul 15; 58 (14). 1325-1329.
5. Beckwith MC, Tyler LS Preventing medication errors with antineoplastics agents, Part I. Hosp Pharm 2002 ; 35: 511-525.
6. Vulto A. Multidisciplinary collaboration. Editorial. EJHPP 2005 ; 11: 3.
7. ASHPguidelines on preventing medication errors with antineoplastic agents. Am J Health- Syst Pharm 2002 ; 59: 1648-1668.
8. Climente Martí M., Jiménez Torres NV Manual para la Atención Farmacéutica. Tercera edición. Edita AFAHPE. Valencia 2005.
9. Nebeker JR, Hoffman JM, Weir CR, Bennett CL, Hurdle JF High rates of adverse drug events in a highly computerized hospital. Arch Intern Med 2005 ; 165: 1111-1116.
10. Cohen MR, Anderson RW, Attilio RM, Green L., Muller RJ, Pruemer JM Preventing medication errors in cancer chemotherapy. Am J Health Syst Pharm 1996 Apr 1; 53 (7). 737-746. (Pubitemid 26112665)
11. Limat S., Drouhin JP, Demesmay K., Tissot E., Jacquet M., Woronoff-Lems MC Incidence and risk factors of preparation errors in a centralized cytotoxic preparation unit. Pharm World Sci 2001 ; 23 (3). 102-106.
12. Leape LL, Bates DW, Cullen DJ et al. Systems analysis of adverse drug events. JAMA 1995 ; 274: 35-43.
13. Bates DW, Cullen DJ, Laird N., Petersen LA, Small SD, Servi D. et al. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group. JAMA 1995 ; 274 (1). 29-34.
14. Alcázera MA, Pérez-Landeiro A., Pandero MI, Rebollar E., Idoipe A., Palomo P. Errors detected in the prescription of antineoplastic agents and their severity level. Eur Hosp Pharm 2001 ; 7: 20-23.
15. Huertas Fernández MJ, Baena-Cañada JM, Martínez Bautista MJ, Arriola Arellano E., García Palacios MV Impact of computerised chemotherapy prescription on the prevention of medication errors. Clin Transl Oncol 2006 ; 8 (11). 821-825.
16. Voeffray M., Pannatier A., Stupp R., Fucina N., Leyvraz L., Wasserfallen JB Effect of computerisation on the quality and safety of chemotherapy prescription. Qual Saf Health Care 2006 ; 15: 418-421.
17. Small M. Effect of an electronic chemotherapy ordering system on prescribing errors. 2006. Abstrac n° 50. J Oncol Pharm Pract 2006 ; 12 (1). 50.
18. Kim GR, Chen AR, Arceci RJ, Mitchell SH, Kokoszka KM, Daniel D. et al. Error reduction in pediatric chemotherapy: computerized order entry and failure modes and effects analysis. Arch Pediatr Adolesc Med 2006 ; 160: 495-498.
19. Bonnabry P., Cingria L., Ackermann M., Sadeghipour F., Bigler L., Mach N. Use of a prospective risk analysis method to improve the safety of the cancer chemotherapy process. Int J Qual Health Care 2006 ; 18 (1). 9-16.
20. Beer J., Dobish R., Chambers C. Physician Order Entry: a missed blessing to Pharmacy? J Oncol Pharm Pract 2002 ; 8: 119-126.
21. Koppel R., Metlay JP, Cohen A., Abaluck B., Localio AR, Kimmel SE et al. Role of computerized physician order entry systems in facilitating medication errors. JAMA 2005 ; 293: 1197-1203. (Pubitemid 40327905)
22. Shulman R., Singer M., Goldstone J., Bellingan G. Medication errors: a prospective cohort study of handwritten and computerised physician order entry in the intensive care unit. Critical Care 2005 ; 9: R516 - R521.
23. Bobb A., Gleason K., Husch M., Feinglass J., Yarnold PR, Noskin GA The epidemiology of prescribing error. The potential impact of computerized prescription order entry. Arch Inter n Med 2004 ; 164: 785-792.
24. Bates DW Using information technology to reduce rates of medication errors in hospital. BMJ 2000 Mar 18; 320 (7237). 788-791.
25. Bates DW, Teich JM, Lee J., Seger D., Kuperman GJ, Ma Luf N. et al. The impact of computerized physician order entry on medication error prevention. J Am Med Inform Assoc 1999 ; 6: 313-321.
26. Bates DW, Leape LL, Cullen DJ, Laird N., Petersen LA, Teich JM et al. Effect of computerized physician order entryc and a team intervention on prevention of serious medication errors. JAMA 1998 Oct 21; 280 (15). 1331-1336.
27. Serrano A., Cavero E., Albert A., Almena A., Jiménez NV Pharmaceutical validation as a process of improving the quality of antineoplastic treatment. Journal Oncology of Pharmacy Practice 2005 ; 11: 45-50.
28. Bhosle M., Sansgiry S. Computerized Physician Order Entry systems: Is the Pharmacists role justified? J Am Med inform Assoc 2004 ; 11: 125-126.
29. Vuelta Arce M., Calabuig Muñoz M., Jornet Montaña S., Canadell Vilarrasa L., Riera Sendra G., Chumillas Chevalier E. et al. Evaluación de la calidad en el process de utilización de fármacos peligrosos: prescripción y preparación. Farm Hosp 2005 ; 29: 119-125.
30. Winterstein AG, Johns TE, Rosenberg EI, Hatton RC, Gonzalez-Rothi R., Kanjanarat P. Nature and causes of clinically significant medication errors in a tertiary care hospital. Am J Health Syst Pharm 2004 ; 61: 1908-1916.
31. Vaida AJ, Cohen MR Point of care bar code medication aadministration: experience in the United states. Farm Hosp 2005 ; 29: 151-152.
32. Kucukarslan SN, Peter M., Mlynarek M. et al. Pharmacists on rounding teams reduce preventable adverse drug events in hospital general medicine units. Arch Intern Med 2003 ; 163: 2014-2018.
33. Leape LL, Cullen DJ, Clapp MD, Burdick E., Demonaco HJ, Erickson JI et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA 1999 ; 282 (3). 267-270.
34. Lam S., Ruby CM Impact of an interdisciplinary team on drug therapy outcomes in a geriatric clinic. Am J Health-Syst Pharm 2005 ; 62: 626-629.
35. Phillips MA Voluntary reporting of medication errors. Am J Health-Syst Pharm 2002 ; 59: 2326-2328.
36. Aguirrezabal A., Alvarez M., Yurrebaso MJ, Vilella ML et al. Deteccion de errors en la prescripcion de chemotherapy. Farm Hosp 2003 ; 27: 219-223.
37. Vanderbroncke J., De Cock P., Robays H. Influence of a computerized program on the quality of prescribing and preparing cytotoxic drugs. J Oncol Pharm Practice 2004 ; 10: 61.
38. The National Coordinating Council for Medication Error Reporting and Prevention (NCC MERP). Use of medication errors rates to compare health care organizations is of no value; June 2002. Available at: http://www.nccmerp.org/ (accessed September 2005 ).